Cargando…

Pandemic driven innovation: A pilot evaluation of an alternative respiratory pathogen collection device()

BACKGROUND: The nasopharyngeal swab is the gold standard collection method for COVID-19, but is invasive and painful, subsequently resulting in poor patient acceptance. This investigation explores the process of developing and validating an alternative respiratory pathogen collection device that rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Thang T., Zeger, Wesley G., Wadman, Michael C., Schnaubelt, Andy T., Barksdale, Aaron N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423874/
https://www.ncbi.nlm.nih.gov/pubmed/36087464
http://dx.doi.org/10.1016/j.ajem.2022.08.047
_version_ 1784778112315162624
author Nguyen, Thang T.
Zeger, Wesley G.
Wadman, Michael C.
Schnaubelt, Andy T.
Barksdale, Aaron N.
author_facet Nguyen, Thang T.
Zeger, Wesley G.
Wadman, Michael C.
Schnaubelt, Andy T.
Barksdale, Aaron N.
author_sort Nguyen, Thang T.
collection PubMed
description BACKGROUND: The nasopharyngeal swab is the gold standard collection method for COVID-19, but is invasive and painful, subsequently resulting in poor patient acceptance. This investigation explores the process of developing and validating an alternative respiratory pathogen collection device that relies on a nasopharyngeal irrigation mechanic. The primary objective was to determine if sufficient pathological sampling can be achieved by mechanism of nasopharyngeal irrigation that is proportionate to the nasopharyngeal swab method. METHODS: The study device was designed using Shapr3D modeling software and fabricated on a fused deposition modeling printer. Fifteen participants were enrolled with each receiving a saline nasopharyngeal washing using the study device. Specimen adequacy was evaluated by two real-time reverse transcriptase polymerase chain reaction (PCR) testing methods to identify the presence of the human RNase P gene. Results were evaluated quantitatively through interpretation of the PCR cycle threshold (Ct). RESULTS: All 15 specimens tested positive for the presence of RNaseP, demonstrating specimen cellularity, adequate extraction of nucleic acids, and the absence of inhibitors to amplification. The mean C(t) value was 29.5 (Applied Biosystems TaqPath RT-qPCR) and 30.7 (NECoV19). All participants felt the study device irrigation procedure was faster than the nasopharyngeal swab, with none experiencing any discomfort from the irrigation mechanism. CONCLUSION: The importance of early diagnostic testing and its role in countermeasures for communicable diseases such as COVID-19 is well established in the literature. Innovation to bolster our testing infrastructure is more important now than ever. This study was successful in developing and validating an alternative nasopharyngeal respiratory pathogen collection device that utilizes fluid debridement as its core mechanic. Data from this pilot study demonstrated the study device was successful in producing high-quality specimens for PCR testing. Feedback from the study participants was also in favor of the study device when compared to the nasopharyngeal swab.
format Online
Article
Text
id pubmed-9423874
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-94238742022-08-30 Pandemic driven innovation: A pilot evaluation of an alternative respiratory pathogen collection device() Nguyen, Thang T. Zeger, Wesley G. Wadman, Michael C. Schnaubelt, Andy T. Barksdale, Aaron N. Am J Emerg Med Article BACKGROUND: The nasopharyngeal swab is the gold standard collection method for COVID-19, but is invasive and painful, subsequently resulting in poor patient acceptance. This investigation explores the process of developing and validating an alternative respiratory pathogen collection device that relies on a nasopharyngeal irrigation mechanic. The primary objective was to determine if sufficient pathological sampling can be achieved by mechanism of nasopharyngeal irrigation that is proportionate to the nasopharyngeal swab method. METHODS: The study device was designed using Shapr3D modeling software and fabricated on a fused deposition modeling printer. Fifteen participants were enrolled with each receiving a saline nasopharyngeal washing using the study device. Specimen adequacy was evaluated by two real-time reverse transcriptase polymerase chain reaction (PCR) testing methods to identify the presence of the human RNase P gene. Results were evaluated quantitatively through interpretation of the PCR cycle threshold (Ct). RESULTS: All 15 specimens tested positive for the presence of RNaseP, demonstrating specimen cellularity, adequate extraction of nucleic acids, and the absence of inhibitors to amplification. The mean C(t) value was 29.5 (Applied Biosystems TaqPath RT-qPCR) and 30.7 (NECoV19). All participants felt the study device irrigation procedure was faster than the nasopharyngeal swab, with none experiencing any discomfort from the irrigation mechanism. CONCLUSION: The importance of early diagnostic testing and its role in countermeasures for communicable diseases such as COVID-19 is well established in the literature. Innovation to bolster our testing infrastructure is more important now than ever. This study was successful in developing and validating an alternative nasopharyngeal respiratory pathogen collection device that utilizes fluid debridement as its core mechanic. Data from this pilot study demonstrated the study device was successful in producing high-quality specimens for PCR testing. Feedback from the study participants was also in favor of the study device when compared to the nasopharyngeal swab. Elsevier Inc. 2022-11 2022-08-30 /pmc/articles/PMC9423874/ /pubmed/36087464 http://dx.doi.org/10.1016/j.ajem.2022.08.047 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Nguyen, Thang T.
Zeger, Wesley G.
Wadman, Michael C.
Schnaubelt, Andy T.
Barksdale, Aaron N.
Pandemic driven innovation: A pilot evaluation of an alternative respiratory pathogen collection device()
title Pandemic driven innovation: A pilot evaluation of an alternative respiratory pathogen collection device()
title_full Pandemic driven innovation: A pilot evaluation of an alternative respiratory pathogen collection device()
title_fullStr Pandemic driven innovation: A pilot evaluation of an alternative respiratory pathogen collection device()
title_full_unstemmed Pandemic driven innovation: A pilot evaluation of an alternative respiratory pathogen collection device()
title_short Pandemic driven innovation: A pilot evaluation of an alternative respiratory pathogen collection device()
title_sort pandemic driven innovation: a pilot evaluation of an alternative respiratory pathogen collection device()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423874/
https://www.ncbi.nlm.nih.gov/pubmed/36087464
http://dx.doi.org/10.1016/j.ajem.2022.08.047
work_keys_str_mv AT nguyenthangt pandemicdriveninnovationapilotevaluationofanalternativerespiratorypathogencollectiondevice
AT zegerwesleyg pandemicdriveninnovationapilotevaluationofanalternativerespiratorypathogencollectiondevice
AT wadmanmichaelc pandemicdriveninnovationapilotevaluationofanalternativerespiratorypathogencollectiondevice
AT schnaubeltandyt pandemicdriveninnovationapilotevaluationofanalternativerespiratorypathogencollectiondevice
AT barksdaleaaronn pandemicdriveninnovationapilotevaluationofanalternativerespiratorypathogencollectiondevice